Benelux Non laboratory based Cannabis Testing Market Size & Outlook, 2026-2034
Benelux Non laboratory based Cannabis Testing Market Insights
- As highlighted in Reed Intelligence analysis, the Benelux Non laboratory based Cannabis Testing Market, worth USD 12.46 Million in 2025, is forecasted to achieve USD 30.65 Million by 2034.
- The Benelux market is anticipated to grow at a CAGR of 10.51% during the period 2026–2034.
- By 2025, Portable Analyzers represented the largest share of the Product Type market size.
- Biosensor Devices is expected to remain the key growth driver within Product Type, registering the fastest CAGR during the forecast period.
![Benelux Non laboratory based Cannabis Testing Market Size, Share & Growth Report By [2034]](https://reedintelligence.com/uploads/charts/benelux-non-laboratory-based-cannabis-testing-market-benelux-product-type-207504.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, Benelux represented 1.06% of the overall global Non laboratory based Cannabis Testing Market size.
- United States is projected to lead the global Non laboratory based Cannabis Testing Market size by 2034.
- Across Europe, Germany is anticipated to hold the dominant position in market size by 2034.
- Russia is forecasted to expand at the fastest pace in Europe, attaining USD 50.85 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 12.46 Million |
| Market Size In 2034 | USD 30.65 Million |
| Largest segment | Portable Analyzers |
| Units | Revenue in USD Million |
| CAGR | 10.51% (2026-2034) |
| Segmnetation Covered | |
| Product Type |
|
| Application |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Benelux Non laboratory based Cannabis Testing Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portable Analyzers | XX.x | XX.x | XX.x | 5.94 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biosensor Devices | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Immunoassay Test Kits | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Software and Data Platforms | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Benelux Non laboratory based Cannabis Testing Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Potency Testing | XX.x | XX.x | XX.x | 5.08 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Contamination Screening | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Terpene Profiling | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Moisture Analysis | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Benelux Non laboratory based Cannabis Testing Market End Use 2026-2034 (USD Million)
| End Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannabis Cultivators | XX.x | XX.x | XX.x | 5.01 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cannabis Processors | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Dispensaries and Retailers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Research Organizations | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.